2024 annual financial data
Ascendis Pharma 2024 Operating margin
Ascendis Pharma 2024 operating margin with verified reported values.
Direct answer
Operating margin was -76.66%.
Operating income was -278,763,000 EUR and net income was -378,084,000 EUR.
Operating cash flow was -306,197,000 EUR.
Get free Ascendis Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 363,641,000 EUR
- Operating income
- -278,763,000 EUR
- Net income
- -378,084,000 EUR
- Operating cash flow
- -306,197,000 EUR